Febuxostat D9
| Product Name | Febuxostat D9 |
|---|---|
| Alternate Names | Febuxostat Stable Isotopes, Stable Isotopes of Febuxostat |
| CAT No. | CS-O-06611 |
| CAS No. | 1246819-50-0 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 325.43 g/mol |
| Mol. For. | C₁₆H₇D₉N₂O₃S |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Febuxostat |
| Purity | 95% |
| Smileys | OC(C(SC(C1=CC(C#N)=C(OC([2H])([2H])C(C([2H])([2H])[2H])([2H])C([2H])([2H])[2H])C=C1)=N2)=C2C)=O |
| Canonical Smiles | CC1=C(SC(=N1)C2=CC(=C(C=C2)OCC(C)C)C#N)C(=O)O |
| InchIKey | BQSJTQLCZDPROO-KIROAFHOSA-N |
| Inchl | InChI=1S/C16H16N2O3S/c1-9(2)8-21-13-5-4-11(6-12(13)7-17)15-18-10(3)14(22-15)16(19)20/h4-6,9H,8H2,1-3H3,(H,19,20)/i1D3,2D3,8D2,9D |
| IUPAC | 2-[3-cyano-4-[1,1,2,3,3,3-hexadeuterio-2-(trideuteriomethyl)propoxy]phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Febuxostat D9 is a deuterated analog of Febuxostat, which is a potent and selective inhibitor of xanthine oxidase, an enzyme that plays a key role in the production of uric acid in the body. Febuxostat D9 is a labeled compound that is commonly used as an internal standard in pharmacokinetic and bioanalytical studies to facilitate quantification of Febuxostat in biological samples.
Febuxostat D9 is an orally-administered medication that is primarily used for the prevention and treatment of hyperuricemia in patients with gout. It works by blocking the activity of xanthine oxidase, which reduces the production of uric acid in the body. This helps to prevent the formation of urate crystals, which can cause inflammation and damage to joints and other tissues.
The chemical name of Febuxostat D9 is 2-(3-cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic acid-d9. Its molecular formula is C16H8D9N3O2S, and its molecular weight is 327.49 g/mol. It is a white to off-white crystalline powder that is sparingly soluble in water.
Febuxostat D9 undergoes extensive hepatic metabolism, primarily via glucuronidation and oxidation, and is excreted primarily in the feces. It has a half-life of approximately 5-8 hours in humans. The recommended dosage for Febuxostat D9 varies depending on the specific condition being treated and the individual patient's medical history and response to treatment. As with any medication, it is important to follow the prescribing physician's instructions and to report any adverse effects or concerns.
Get an Instant Quote
Related Compounds
Febuxostat D7 | Febuxostat D5 | Febuxostat D3 |